目的:探讨不同剂量右美托咪定联合盐酸艾司氯胺酮对机器人辅助腹腔镜下根治性前列腺切除术(RARP)患者的应用效 果及对其血流动力学、认知功能、谵妄和不良反应发生率的影响。方法:前瞻性选取南京大学医学院附属鼓楼医院于 2021 年 1 月—2024 年 1 月收治的 80 例 RARP 患者,分为 3 组,A 组、B 组各 25 例,C 组 30 例。A 组给予 0.2 mg/kg 盐酸艾司氯胺酮 + 生理盐水,B组给予0.2 mg/kg盐酸艾司氯胺酮+0.5 μg/(kg·h)右美托咪定,C组给予0.2 mg/kg盐酸艾司氯胺酮+0.7 μg/(kg·h) 右美托咪定。对比三组患者血流动力学指标、Ramesay 镇静评分、疼痛视觉模拟评分法(VAS)评分、苏醒质量、蒙特利尔 认知评估量表(MoCA)评分、谵妄及不良反应发生率。结果:气管插管即刻和手术开始时,三组患者血氧饱和度均降低, B、C 两组血氧饱和度高于 A 组(P<0.05),三组患者心率、平均动脉压均升高,B、C 两组心率、平均动脉压低于 A 组 (P<0.05);B 组与 C 组患者各时点血流动力学指标比较,差异均无统计学意义(P>0.05)。三组患者手术结束清醒后、 术后 2 h、术后 6 h Ramesay 镇静评分比较,差异无统计学意义(P>0.05),术后 2 h、术后 6 h B、C 两组 VAS 评分均低于 A 组(P<0.05),B 组与 C 组差异无统计学意义(P>0.05)。B 组拔除气管插管时间、呼叫自睁眼时间短于 A 组和 C 组(P<0.05), B 组和 C 组自主呼吸恢复时间短于 A 组,且术中丙泊酚用量、舒芬太尼用量少于 A 组(P<0.05)。术后 1 d B、C 两组 MoCA 评分高于 A 组(P<0.05),B 组与 C 组比较差异无统计学意义(P>0.05)。B 组和 C 组谵妄发生率低于 A 组(P<0.05),B 组不良反应总发生率低于 A 组和 C 组(P<0.05)。结论:右美托咪定联合盐酸艾司氯胺酮在 RARP 患者中的应用效果显著, 可减轻患者术后血流动力学指标波动,提升术后镇痛效果和苏醒质量,减少术中丙泊酚、舒芬太尼用量,改善术后认知功能 水平,降低谵妄发生率,且应用 0.5μg/(kg·h)剂量的右美托咪定效果更优。
Objective: To investigate the effect of different doses of dexmedetomidine combined with esketamine hydrochloride in patients undergoing robot-assisted laparoscopic radical prostatectomy (RARP) and its influence on hemodynamics, cognitive function, delirium, and the incidence of adverse reactions. Methods: 80 patients who underwent RARP from January 2021 to January 2024 in Drum Tower Hospital Affiliated to Nanjing University Medical School were prospectively selected and divided into three groups: 25 patients in the group A and group B, 30 patients in group C. Group A was given 0.2 mg/kg esketamine hydrochloride + physiological saline, group B was given 0.2 mg/kg esketamine hydrochloride + 0.5 μg/(kg·h) dexmedetomidine, and group C was given 0.2 mg/kg esketamine hydrochloride + 0.7 μg/(kg·h) dexmedetomidine. Hemodynamic indexes, Ramesay sedation score, visual analog scale (VAS) score, quality of awakening, Montreal cognitive assessment (MoCA) score, delirium, and incidence of adverse reactions were compared among the three groups. Results: At the moment of endotracheal intubation and the beginning of surgery, the oxygen saturation decreased in the three groups of patients, and it was higher in group B and group C than group A (P<0.05). Heart rate and mean arterial pressure increased in the three groups of patients, and they were lower in group B and group C than group A (P<0.05). The comparison of hemodynamic indexes of patients between group B and group C at each point in time showed no statistically significant difference (P>0.05). The differences in Ramesay sedation scores at postoperative wakefulness, 2 h and 6 h after surgery among the three groups of patients were not statistically significant (P>0.05). VAS scores at 2 h and 6 h after surgery in group B and group C were lower than group A (P<0.05), and the differences between group B and group C were not statistically significant (P>0.05). The time for removing tracheal intubation and calling for the time of self-opening of eyes were shorter in group B than those in group A and group C (P<0.05), the recovery time of spontaneous respiration in group B and C was shorter than that in group A, and the intraoperative dosages of propofol and sufentanil were less than those in group A (P<0.05). The MoCA scores at 1 d after surgery in group B and C were higher than those in group A (P<0.05), and the difference between group B and C was not statistically significant (P>0.05). The incidence of delirium in group B and C was lower than that in group A (P<0.05), and the total incidence of adverse reactions in group B was lower than that in group A and C (P<0.05). Conclusion: Dexmedetomidine combined with esketamine hydrochloride in patients with RARP can effectively reduce the fluctuation of postoperative hemodynamic indexes of patients, enhance the postoperative analgesic effect and the quality of awakening, lower the dosage of intraoperative propofol and sufentanil, improve the level of postoperative cognitive function, and decrease the incidence of delirium, and applying a dose of dexmedetomidine at the dose of 0.5μg/(kg·h) was more effective.
基金项目:国家自然科学基金青年科学基金项目(H0903)
Foundation Item: National Natural Science Foundation of China (H0903)
引用格式:宿明艳,刘晓杰,崔士和,等 . 不同剂量右美托咪定联合盐酸艾司氯胺酮对机器人辅助腹腔镜下根治性前列腺切除术患者的影响 [J]. 机器人外科学杂志(中英文),2025,6(2):245-250.
Citation: SU M Y, LIU X J, CUI S H, et al. Effect of different doses of dexmedetomidine combined with esketamine hydrochloride in patients undergoing robot-assisted laparoscopic radical prostatectomy[J]. Chinese Journal of Robotic Surgery, 2025, 6(2): 245-250.
通讯作者(Corresponding Author):周瑜(ZHOU Yu),Email:153244813@qq.com
[1] 孙艳芳 , 黄敏 , 宋晓雨 , 等 . 超声引导下星状神经节阻滞对机器人 辅助腹腔镜下前列腺癌根治术患者术中应激反应水平及术后认知 功能恢复情况的影响 [J]. 机器人外科学杂志 ( 中英文 ), 2024, 5(3): 347-354.
[2] 常梦月 , 彭良玉 , 顾小萍 . 上午和下午手术对择期行机器人辅助腹腔 镜下前列腺癌根治术的老年病人围术期并发症的影响 [J]. 实用老年 医学 , 2023, 37(9): 943-946.
[3] 丁思伟 , 代坤含 , 秦梓榛 , 等 . 机器人辅助腹腔镜下前列腺癌根治 术中保留耻骨前列腺韧带对尿控恢复的影响 [J]. 重庆医学 , 2023, 52(22): 3419-3424.
[4] 梁安施 , 谢彩叶 . 系统免疫炎症营养指数对老年腹腔镜前列腺癌根 治术患者术后谵妄的预测价值 [J]. 中国性科学 , 2023, 32(11): 30-34.
[5] 陈燕 , 王飞飞 , 石普峰 , 等 .Bis 监测联合 Ac 监测对前列腺癌根治 术患者麻醉苏醒质量及术后谵妄的影响 [J]. 贵州医药 , 2022, 46(12): 1868-1869.
[6] 孙袁鸣 , 夏晓琼 , 高翔 , 等 . 小剂量艾司氯胺酮联合右美托咪定对乳 腺癌根治手术后患者睡眠及恢复的影响 [J]. 黑龙江医药 , 2024, 37(1): 11-16.
[7] 和谦 , 蒋天赐 , 周武童 , 等 . 亚麻醉剂量艾司氯胺酮复合右美托咪定 对妇科手术患者焦虑抑郁情绪及炎症反应的影响 [J]. 新乡医学院学 报 , 2024, 41(4): 326-332.
[8] 《临床泌尿外科杂志》编辑部 . 欧洲泌尿学会更新前列腺癌诊疗指 南 [J]. 临床泌尿外科杂志 , 2006, 21(5): 399-400.
[9] 范之丹 , 邵静 , 丁炜宏 .Dex 对行三孔法 LRP 术的高龄前列腺癌患者 术后镇静情况、神经功能及脑氧代谢的影响 [J]. 海南医学院学报 , 2020, 26(7): 524-528.
[10] 方铮 , 徐雯 , 杨旅军 . 右美托咪定对老年患者机器人腹腔镜下前列腺 癌根治手术谵妄的影响 [J]. 老年医学与保健 , 2016, 22(2): 97-99.
[11] 张宁 , 朱鸣雷 , 刘晓红 . 美国老年医学会发布防治老年患者术后谵妄 临床指南解读 [J]. 中华老年医学杂志 , 2015, 34(1): 1-2.
[12] Bergengren O, Pekala K R, Matsoukas K, et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review[J]. Eur Urol, 2023, 84(2): 191-206.
[13] 孙大鹏 , 申兵 , 乔芳芳 , 等 . 机器人辅助腹腔镜下前列腺癌根治性切 除术改良仰卧位与常规体位的对照研究 [J]. 机器人外科学杂志 ( 中 英文 ), 2022, 3(2): 115-119.
[14] 侯瑜 , 王子轩 , 聂丽霞 , 等 . 压力支持通气联合低吸入氧浓度对行机 器人辅助前列腺癌根治术的老年患者全麻苏醒期肺不张的影响 [J]. 中华老年医学杂志 , 2023, 42(12): 1447-1452.
[15] 史晨丽 , 刘凤青 , 韩雪 , 等 . 老年髋部骨折患者术后谵妄的影响因素 分析 [J]. 江苏医药 , 2023, 49(10): 1053-1056.
[16] 程丽莎 , 王照飞 , 徐韡韡 , 等 . 不同剂量艾司氯胺酮复合右美托咪定 在食管癌术后自控静脉镇痛患者中的应用效果对比 [J]. 实用癌症杂 志 , 2024, 39(7): 1155-1158, 1166.
[17] 邓东香 , 吴多志 . 艾司氯胺酮联合右美托咪定及利多卡因麻醉诱导 抑制气管插管反应 [J]. 新医学 , 2024, 55(5): 335-341.
[18] 汪东升 , 张从利 , 张阳 , 等 . 右美托咪定联合艾司氯胺酮麻醉在冠心 病非心脏手术中效果研究 [J]. 沈阳医学院学报 , 2024, 26(3): 261-266.
[19] 李洁 , 高东艳 . 不同剂量右美托咪定对妇科恶性肿瘤腹腔镜手术 患者炎性因子和免疫功能的影响 [J]. 肿瘤研究与临床 , 2023, 35(1): 13-17.
[20] 李晓丽 , 卜令标 , 巩岩 , 等 . 艾司氯胺酮与舒芬太尼联合右美托咪定 在经皮椎体成形术中的应用效果比较 [J]. 实用临床医学 , 2024, 25(1): 29-33.
[21] 汪启明 , 梅楷波 , 熊归祥 . 右美托咪定联合芬太尼与艾司氯胺酮对老 年全麻手术患者术后谵妄及神经功能的影响 [J]. 临床合理用药杂志 , 2024, 17(20): 96-99.
[22] 王亚群 , 夏西尚 , 汪东学 , 等 . 右美托咪定复合艾司氯胺酮用于老 年脊柱手术患者的临床研究 [J]. 中国临床药理学杂志 , 2024, 40(14): 2013-2017.